Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Gene Expression Profiling × Clear all

NCT00516750 2013-07-10

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

Phase 2 Terminated

Urinary Bladder Neoplasms